Many older Americans on Medicare are shocked to find that the newly approved Covid shots aren't covered, leading to hefty out-of-pocket expenses. Health officials claim coverage should be available, but patients report otherwise. What's going on?
A groundbreaking study reveals that beta blockers may not benefit heart attack patients with preserved heart function. Discover the surprising results that could change treatment protocols.
A new vaccine policy has been announced, allowing boosters for high-risk patients while leaving healthy adults and children in a gray area. Experts warn this could lead to fewer vaccinations and rising COVID-19 cases.
The American College of Cardiology urges heart disease patients to get vaccinated against respiratory illnesses like RSV and COVID-19, contradicting recent U.S. vaccine access restrictions.
Lilly's new oral pill, Orforglipron, has shown promising results in reducing weight and improving blood sugar levels in diabetes patients. With nearly 4% rise in shares, the drug is on track for FDA approval.
Surgeons have achieved a remarkable milestone by transplanting a genetically modified pig's lung into a brain-dead human, showcasing the potential of xenotransplantation amidst ongoing organ shortages. However, experts caution that much work remains before this can be considered a viable option for living patients.
Stanford researchers have developed a revolutionary brain-computer interface that decodes inner speech, allowing paralyzed patients to communicate without muscle movement. With a unique mental privacy safeguard, this technology could change lives!
A new retrospective study indicates that while GLP-1 receptor agonists for diabetes may slightly increase the risk of new-onset diabetic retinopathy, they also significantly reduce the risk of vision loss. Experts emphasize the importance of regular eye examinations for patients.
The Chikungunya virus is spreading rapidly across cities in China and beyond, prompting health warnings and quarantine measures. Discover how the virus spreads and which countries are affected.
In a surprising turn of events, the FDA has allowed Sarepta Therapeutics to resume shipments of its gene therapy, Elevidys, for younger Duchenne muscular dystrophy patients who can walk, despite concerns over previous fatalities.
